189 related articles for article (PubMed ID: 36230994)
1. Alterations of Lipid Metabolism in the Heart in Spontaneously Hypertensive Rats Precedes Left Ventricular Hypertrophy and Cardiac Dysfunction.
Bednarski TK; Duda MK; Dobrzyn P
Cells; 2022 Sep; 11(19):. PubMed ID: 36230994
[TBL] [Abstract][Full Text] [Related]
2. The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.
Iemitsu M; Shimojo N; Maeda S; Irukayama-Tomobe Y; Sakai S; Ohkubo T; Tanaka Y; Miyauchi T
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H136-44. PubMed ID: 18456726
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
4. Stearoyl-CoA desaturase 1 deficiency reduces lipid accumulation in the heart by activating lipolysis independently of peroxisome proliferator-activated receptor α.
Bednarski T; Olichwier A; Opasinska A; Pyrkowska A; Gan AM; Ntambi JM; Dobrzyn P
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2029-2037. PubMed ID: 27751891
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
[TBL] [Abstract][Full Text] [Related]
6. Small-conductance Ca2+-activated K+ current is upregulated via the phosphorylation of CaMKII in cardiac hypertrophy from spontaneously hypertensive rats.
Mizukami K; Yokoshiki H; Mitsuyama H; Watanabe M; Tenma T; Takada S; Tsutsui H
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(6):H1066-74. PubMed ID: 26297230
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation of left ventricular substrate metabolism, perfusion, and dysfunction in the spontaneously hypertensive rat model of hypertrophy using small-animal PET/CT imaging.
Hernandez AM; Huber JS; Murphy ST; Janabi M; Zeng GL; Brennan KM; O'Neil JP; Seo Y; Gullberg GT
J Nucl Med; 2013 Nov; 54(11):1938-45. PubMed ID: 24092939
[TBL] [Abstract][Full Text] [Related]
8. Dietary-induced obesity hastens the progression from concentric cardiac hypertrophy to pump dysfunction in spontaneously hypertensive rats.
Majane OH; Vengethasamy L; du Toit EF; Makaula S; Woodiwiss AJ; Norton GR
Hypertension; 2009 Dec; 54(6):1376-83. PubMed ID: 19841294
[TBL] [Abstract][Full Text] [Related]
9. Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy.
Dobrzyn P; Pyrkowska A; Duda MK; Bednarski T; Maczewski M; Langfort J; Dobrzyn A
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1348-58. PubMed ID: 23632628
[TBL] [Abstract][Full Text] [Related]
10. [PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats].
Chen HJ; Chen JZ; Wang XX; Yu M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 36(5):470-6. PubMed ID: 17924466
[TBL] [Abstract][Full Text] [Related]
11. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
[TBL] [Abstract][Full Text] [Related]
12. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
13. Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat.
Tang Y; Mi C; Liu J; Gao F; Long J
Cardiovasc Pathol; 2014; 23(2):101-6. PubMed ID: 24388463
[TBL] [Abstract][Full Text] [Related]
14. Properties of ventricular myocytes isolated from the hypertrophied and failing hearts of spontaneously hypertensive rats.
Emanuel K; Mackiewicz U; Pytkowski B; Lewartowski B
J Physiol Pharmacol; 1999 Jun; 50(2):243-58. PubMed ID: 10424720
[TBL] [Abstract][Full Text] [Related]
15. Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats.
Li X; Han J; Li L; Wang KJ; Hu SJ
Int J Cardiol; 2013 Oct; 168(4):3340-7. PubMed ID: 23664044
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Modulation by Medium-Chain Triglycerides Reduces Oxidative Stress and Ameliorates CD36-Mediated Cardiac Remodeling in Spontaneously Hypertensive Rat in the Initial and Established Stages of Hypertrophy.
Saifudeen I; Subhadra L; Konnottil R; Nair RR
J Card Fail; 2017 Mar; 23(3):240-251. PubMed ID: 27530817
[TBL] [Abstract][Full Text] [Related]
17. Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy.
Lee GR; Bell D; Kelso EJ; Argent CC; McDermott BJ
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H425-32. PubMed ID: 14988072
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z
Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418
[TBL] [Abstract][Full Text] [Related]
19. Altered heart and kidney phospholipid fatty acid composition are associated with cardiac hypertrophy in hypertensive rats.
Kim OY; Jung YS; Cho Y; Chung JH; Hwang GS; Shin MJ
Clin Biochem; 2013 Aug; 46(12):1111-1117. PubMed ID: 23608354
[TBL] [Abstract][Full Text] [Related]
20. Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
Shimojo N; Miyauchi T; Iemitsu M; Irukayama-Tomobe Y; Maeda S; Ohkubo T; Tanaka Y; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S181-5. PubMed ID: 15838274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
